We are live on
!
Find out more
CRC
Curi RMB Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
18.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.52%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+323.6%
AUM
$2.81B
AUM Growth
+$127M
(+4.7%)
Cap. Flow
-$91.8M
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
504
New
39
Increased
117
Reduced
218
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$21.3M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$14.7M |
| 3 |
Salesforce
CRM
|
+$14M |
| 4 |
iShares MBS ETF
MBB
|
+$11.5M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$7.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$35M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$14.6M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$14.5M |
| 4 |
TJX Companies
TJX
|
+$8.92M |
| 5 |
Apple
AAPL
|
+$6.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.09% |
| 2 | Technology | 16.43% |
| 3 | Healthcare | 12.41% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Schwab US Broad Market ETF
SCHB
$44.9B
| $834K | 0.03% |
55,821
-2,148
| -4% | -$32.3K |
|
302
Waterstone Financial
WSBF
$375M
| $831K | 0.03% |
48,194
| – | – |
|
303
Insulet
PODD
$9.79B
| $798K | 0.03% |
2,711
-1,666
| -38% | -$459K |
|
304
MPLX
MPLX
$59.7B
| $798K | 0.03% |
24,286
| – | – |
|
305
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.6B
| $779K | 0.03% |
26,231
+377
| +1% | +$10.8K |
|
306
Veeva Systems
VEEV
$37.4B
| $777K | 0.03% |
4,814
-82
| -2% | -$14K |
|
307
Baxter International
BAX
$14.2B
| $773K | 0.03% |
15,175
+9,664
| +175% | +$519K |
|
308
Starbucks
SBUX
$120B
| $773K | 0.03% |
7,796
+274
| +4% | +$25.9K |
|
309
TE Connectivity
TEL
$62.6B
| $770K | 0.03% |
6,707
-36
| -0.5% | -$4.28K |
|
310
Sonoco
SON
$5.74B
| $769K | 0.03% |
12,675
| – | – |
|
311
AstraZeneca
AZN
$250B
| $768K | 0.03% |
5,661
-594
| -9% | -$74.5K |
|
312
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $765K | 0.03% |
19,662
+1,220
| +7% | +$46.7K |
|
313
Champion Homes
SKY
$5.14B
| $743K | 0.03% |
14,431
-1,182
| -8% | -$62.9K |
|
|
UMH
314
UMH Properties
UMH
$1.36B
| $735K | 0.03% |
45,647
| – | – |
|
|
ADAM
315
Adamas Trust
ADAM
$883M
| $722K | 0.03% |
70,507
+11,398
| +19% | +$121K |
|
316
Meta Platforms (Facebook)
META
$1.51T
| $715K | 0.03% |
5,938
+46
| +0.8% | +$5.4K |
|
317
Independent Bank
INDB
$3.99B
| $705K | 0.03% |
8,347
| – | – |
|
318
iShares Core MSCI EAFE ETF
IEFA
$196B
| $701K | 0.02% |
11,365
-3,126
| -22% | -$184K |
|
319
Atlassian
TEAM
$37.8B
| $698K | 0.02% |
5,428
+836
| +18% | +$133K |
|
320
Procter & Gamble
PG
$339B
| $690K | 0.02% |
4,554
+280
| +7% | +$39.3K |
|
321
iShares MSCI Japan ETF
EWJ
$23B
| $690K | 0.02% |
+12,675
| New | +$667K |
|
|
CHY
322
Calamos Convertible and High Income Fund
CHY
$1.06B
| $689K | 0.02% |
65,315
-4,785
| -7% | -$53.3K |
|
323
Boeing
BA
$185B
| $688K | 0.02% |
3,614
-164
| -4% | -$26.8K |
|
324
Energy Transfer Partners
ET
$69.3B
| $688K | 0.02% |
57,932
| – | – |
|
325
Vanguard Morningstar Value ETF
VTV
$191B
| $681K | 0.02% |
4,854
+393
| +9% | +$54.1K |
|
Similar funds
AC
RMDI
F
EW
DSC
O
ACM
AS
Curi RMB Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Curi RMB Capital held 504 positions worth $2.81B, up 4.7% from $2.68B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Curi RMB Capital withdrew a net $91.8M in Q4 2022, closing 41 positions and reducing 218 holdings. Its most notable exit was Edwards Lifesciences, an estimated $35M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Curi RMB Capital opened a new position in iShares MBS ETF worth $11.6M.
- Curi RMB Capital's largest Q4 2022 buy was iShares MBS ETF: 125,026 shares worth $11.6M.
- Curi RMB Capital added most to iShares MSCI Emerging Markets ETF in Q4 2022, an estimated $21.3M increase.
- Curi RMB Capital's biggest Q4 2022 reduction was TJX Companies, cutting an estimated $8.92M.
- Curi RMB Capital fully exited Edwards Lifesciences in Q4 2022, selling an estimated $35M.
- Curi RMB Capital's ten largest holdings make up 17% of its $2.81B portfolio in Q4 2022.
- Curi RMB Capital opened 39 new positions and closed 41 in Q4 2022.
- Curi RMB Capital's portfolio value rose 4.7% quarter-over-quarter to $2.81B.
Based on Curi RMB Capital's 13F filing for Q4 2022, filed 14 Feb 2023.